9-134882543-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004108.3(FCN2):āc.118C>Gā(p.Leu40Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,461,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004108.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCN2 | NM_004108.3 | c.118C>G | p.Leu40Val | missense_variant | 2/8 | ENST00000291744.11 | NP_004099.2 | |
FCN2 | XM_011518392.4 | c.85C>G | p.Leu29Val | missense_variant | 2/8 | XP_011516694.1 | ||
FCN2 | NM_015837.3 | c.101-759C>G | intron_variant | NP_056652.1 | ||||
FCN2 | XM_006717015.5 | c.68-759C>G | intron_variant | XP_006717078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCN2 | ENST00000291744.11 | c.118C>G | p.Leu40Val | missense_variant | 2/8 | 1 | NM_004108.3 | ENSP00000291744.6 | ||
FCN2 | ENST00000350339.3 | c.101-759C>G | intron_variant | 5 | ENSP00000291741.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251406Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135874
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727220
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.118C>G (p.L40V) alteration is located in exon 2 (coding exon 2) of the FCN2 gene. This alteration results from a C to G substitution at nucleotide position 118, causing the leucine (L) at amino acid position 40 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at